Robert W. Baird Lowers Bowman Consulting Group (NASDAQ:BWMN) Price Target to $28.00

Bowman Consulting Group (NASDAQ:BWMN) had its price objective lowered by analysts at Robert W. Baird from $29.00 to $28.00 in a report issued on Thursday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Robert W. Baird’s price target would indicate a potential upside of 20.22% from the company’s previous close.

Separately, Bank of America reduced their price objective on Bowman Consulting Group from $36.50 to $30.50 and set a “buy” rating on the stock in a research report on Wednesday.

Bowman Consulting Group Price Performance

Bowman Consulting Group stock opened at $23.29 on Thursday. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.43 and a current ratio of 1.43. Bowman Consulting Group has a 52 week low of $17.90 and a 52 week high of $42.39. The stock has a market capitalization of $408.27 million, a P/E ratio of -29.48 and a beta of 1.32. The stock has a fifty day moving average of $23.22 and a 200-day moving average of $23.87.

Bowman Consulting Group (NASDAQ:BWMN) last issued its quarterly earnings data on Tuesday, March 11th. The company reported $0.33 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.06). The firm had revenue of $113.22 million for the quarter, compared to the consensus estimate of $110.00 million. Bowman Consulting Group had a positive return on equity of 3.76% and a negative net margin of 2.62%.

Insider Buying and Selling

In other Bowman Consulting Group news, insider Robert Alan Hickey sold 2,500 shares of the company’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $22.46, for a total value of $56,150.00. Following the sale, the insider now owns 188,177 shares in the company, valued at approximately $4,226,455.42. The trade was a 1.31 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 20.40% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Bowman Consulting Group

Institutional investors have recently made changes to their positions in the stock. BNP Paribas Financial Markets bought a new stake in shares of Bowman Consulting Group in the 4th quarter valued at about $42,000. Quantbot Technologies LP grew its position in shares of Bowman Consulting Group by 115.6% in the 3rd quarter. Quantbot Technologies LP now owns 3,893 shares of the company’s stock valued at $94,000 after buying an additional 2,087 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of Bowman Consulting Group in the 4th quarter valued at about $147,000. Wells Fargo & Company MN grew its position in shares of Bowman Consulting Group by 55.0% in the 4th quarter. Wells Fargo & Company MN now owns 6,524 shares of the company’s stock valued at $163,000 after buying an additional 2,316 shares during the last quarter. Finally, Comerica Bank grew its position in shares of Bowman Consulting Group by 12.8% in the 4th quarter. Comerica Bank now owns 10,781 shares of the company’s stock valued at $269,000 after buying an additional 1,220 shares during the last quarter. Institutional investors own 63.20% of the company’s stock.

About Bowman Consulting Group

Bowman Consulting Group Ltd. provides a range of real estate, energy, infrastructure, and environmental management solutions in the United States. It offers civil and site engineering services, such as conceptual land planning, environmental consulting and permitting, planning/zoning and entitlements, roadway and highway designs, erosion and sediment designs, stormwater management designs, construction administration, traffic studies, floodplain studies, and utility relocation designs; and commissioning and energy efficiency services comprise construction observation, direct systems functional performance testing, system development readiness checklist, post occupancy review, review of construction documents, deferred/seasonal functional testing, final commissioning report, and commissioning review of submittals.